Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]
Front ImmunolLi N, Hu J, Bao G, Cai Z.
europepmc +1 more source
Diagnostic Challenges in Sessile Serrated Lesions: Progression to Adenocarcinoma in a High-Risk Patient. [PDF]
Am J Case RepAhmed S, Kaur H, Diab MO, Nadir A.
europepmc +1 more source
Diagnostic Utility of a Cost-Effective Four-Gene Next Generation Sequencing Panel for Predicting Papillary Thyroid Carcinoma in Indeterminate Thyroid Cytology: A Multicenter Study in China. [PDF]
Cancer MedJiao Q +8 more
europepmc +1 more source
Data Mining for Identification of Targets and Repurposed Drugs to Eliminate Persistent Chronic Myeloid Leukaemia Stem Cells: Targeting RAS/RAF Signalling. [PDF]
Oncol ResAnggriawan IMB, Jørgensen HG.
europepmc +1 more source
Metastatic melanoma with heterologous bone after neoadjuvant immunotherapy: diagnostic insights. [PDF]
PathologicaPepe L +8 more
europepmc +1 more source
Synergistic antitumor effect of oroxylin A and donafenib in hepatocellular carcinoma through tumor protein p53 signaling pathway activation. [PDF]
World J GastroenterolZhang MY +5 more
europepmc +1 more source
Non-receptor tyrosine kinase signaling pathways and therapeutic implications. [PDF]
Signal Transduct Target TherHossain MDA +4 more
europepmc +1 more source
Single-cell omics in investigating the effect of CAFs with KRAS overexpression on the malignant progression of anaplastic thyroid cancer. [PDF]
J Chin Med AssocSun H +5 more
europepmc +1 more source
Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. [PDF]
Oncol ResTsubaki M, Matsuo T, Komori R.
europepmc +1 more source